Quanticate Sponsors PhD Research into Response-Adaptive Trial Design

Published on: 

Applied Clinical Trials

Quanticate, a data-focused CRO, has announced that it is partnering with Lancaster University to sponsor a STOR-i PhD project. The partnership will support research into optimizing clinical trial design for rare disease and the role of response-adaptive randomization.

Read the full release here.